Your browser doesn't support javascript.
loading
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.
Navaridas, Raúl; Vidal-Sabanés, Maria; Ruiz-Mitjana, Anna; Altés, Gisela; Perramon-Güell, Aida; Yeramian, Andree; Egea, Joaquim; Encinas, Mario; Gatius, Sonia; Matias-Guiu, Xavier; Dolcet, Xavier.
Afiliação
  • Navaridas R; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Vidal-Sabanés M; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Ruiz-Mitjana A; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Altés G; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Perramon-Güell A; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Yeramian A; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Egea J; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Encinas M; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Gatius S; Oncologic Pathology Group, Department of Basic Medical Sciences, Biomedical Research Institute of Lleida (IRBLleida), CIBERONC., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Matias-Guiu X; Oncologic Pathology Group, Department of Basic Medical Sciences, Biomedical Research Institute of Lleida (IRBLleida), CIBERONC., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
  • Dolcet X; Developmental and Oncogenic Signalling Group, Department of Basic Medical Sciences and Department of Experimental Medicine, Institut de Recerca Biomèdica de Lleida, IRBLleida. University of Lleida, UdL., Av. Rovira Roure 80, Lleida, Catalonia, 25198, Spain.
Adv Sci (Weinh) ; 10(32): e2303134, 2023 11.
Article em En | MEDLINE | ID: mdl-37749866

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Neoplasias do Endométrio Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Neoplasias do Endométrio Idioma: En Ano de publicação: 2023 Tipo de documento: Article